# 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients

> **NCT01832116** · PHASE1 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 11 (actual)

## Conditions studied

- Ovarian Neoplasms
- Ovarian Diseases
- Adnexal Diseases
- Pancreatic Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Pancreatic Diseases

## Interventions

- **DRUG:** 89Zr-MMOT0530A

## Key facts

- **NCT ID:** NCT01832116
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832116, "89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01832116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*